Critical Therapeutics clinical trials
Acquired by Chiesi Farmaceutici S.p.A., Jul 28, 2009 · source ↗
The registry lists 5 studies whose lead sponsor is Critical Therapeutics. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 3, 2008.
Before and after it joined Chiesi Farmaceutici S.p.A.
- First submitted before Critical Therapeutics became part of Chiesi Farmaceutici S.p.A.
- 5
- First submitted after Critical Therapeutics became part of Chiesi Farmaceutici S.p.A.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Critical Therapeutics5 studies
Something wrong with this grouping? Tell us on the Chiesi Farmaceutici S.p.A. page.
Studies
Recruiting first, then most recently updated. Showing 5 of 5. All Chiesi Farmaceutici S.p.A. studies →
- Zileuton CR vs Placebo in Poorly Controlled Asthma Patients on Moderate Dose ICSTerminatedNCT00486343Phase 4
Sponsor listed in the registry: Critical Therapeutics · First submitted before Critical Therapeutics became part of Chiesi Farmaceutici S.p.A.
- Assessment of PFT, Safety, and PK of Zileuton Injection in Asthma PatientsCompletedNCT00534625Phase 2
Sponsor listed in the registry: Critical Therapeutics · First submitted before Critical Therapeutics became part of Chiesi Farmaceutici S.p.A.
- Safety Study of Zileuton Injection in Patients With AsthmaCompletedNCT00299065Phase 1/2
Sponsor listed in the registry: Critical Therapeutics · First submitted before Critical Therapeutics became part of Chiesi Farmaceutici S.p.A.
- Study of Oral Zileuton in the Treatment of Moderate to Severe Facial Acne VulgarisStatus unknownNCT00098358Phase 2
Sponsor listed in the registry: Critical Therapeutics · First submitted before Critical Therapeutics became part of Chiesi Farmaceutici S.p.A.
- CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB)TerminatedNCT00107666Phase 2
Sponsor listed in the registry: Critical Therapeutics · First submitted before Critical Therapeutics became part of Chiesi Farmaceutici S.p.A.